ENHERTU® Demonstrated Robust and Durable Tumor Response of 54.9% in Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer
First HER2 directed therapy to show a strong tumor response in this population Data from…
First HER2 directed therapy to show a strong tumor response in this population Data from…
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion"), a leading provider of cloud-based…
FORT WORTH, Texas--(BUSINESS WIRE)--Metals Acquisition Corp. (NYSE: MTAL.U) (the “Company”) announced that, commencing September 20,…
First ENHERTU trial in Western patients with gastric cancer Efficacy and safety results consistent with…
DUBLIN--(BUSINESS WIRE)--The "Buy Now Pay Later in Australia - Industry Market Research Report" has been…
DUBLIN--(BUSINESS WIRE)--The "India Skincare Market Assessment and Forecasts to 2025" report has been added to…
SINGAPORE--(BUSINESS WIRE)--#insurance--AM Best has revised the Long-Term Issuer Credit Rating (Long-Term ICR) outlook to stable…
NEW YORK & BANGALORE, India--(BUSINESS WIRE)--#Cloud--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading…
DUBLIN--(BUSINESS WIRE)--The "Vietnam Crawler Excavator Market - Strategic Assessment & Forecast 2021-2027" report has been…
DUBLIN--(BUSINESS WIRE)--The "Malaysia Crawler Excavator Market - Strategic Assessment & Forecast 2021-2027" report has been…